News
Sex differences provide insight into glioblastoma treatment
- Author:
- Caleb Rans
According to a quantitative imaging and molecular analysis of 63 patients with glioblastoma, women appear to fare better than men with standard-of...
News
Chemo for solid tumors and risk of tMDS/AML
- Author:
- Caleb Rans
Chemotherapy for solid tumors is associated with an increased risk of therapy-related myelodysplastic syndromes or acute myeloid leukemia (tMDS/...
News
Higher AML, MDS risk linked to solid tumor chemotherapy
- Author:
- Caleb Rans
Most tMDS/AML cases expected to occur within the next 5 years will be attributable to chemotherapy, the researchers reported.
News
Anticoagulation shows promise in concurrent lupus nephritis, thrombotic microangiopathy
- Author:
- Caleb Rans
Results come from the largest multicenter cohort study in these patients.
News
Clinical Guidance: Thiopurine agents for the treatment of IBD
- Author:
- Caleb Rans
Thiopurines can reduce steroid use and increase anti–tumor necrosis factor blood values.
News
AGA Clinical Practice Update: Endoscopic submucosal dissection
- Author:
- Caleb Rans
Uptake and training in the United States have been slow, although the technique is recommended as safe and cost effective.
News
HCC screening linked with improved tumor detection
- Author:
- Caleb Rans
Screening patients with cirrhosis for hepatocellular carcinoma is an underutilized early cancer–detection technique.
News
AHA: Statins associated with high degree of safety
- Author:
- Caleb Rans
Rumors of statins’ adverse side effects are greatly exaggerated.
News
Short-term lung function better predicts mortality risk in SSc
- Author:
- Caleb Rans
Surrogate measures of lung disease progression may help to determine the need for early intervention.
News
Surgical model to study reflux esophagitis after esophagojejunostomy
- Author:
- Caleb Rans
Post esophagojejunostomy in rats, a wound repair process produces metaplastic columnar-lined esophagus likely independent of progenitor cell...
News
AEDs strongly linked to rare serious skin reactions
- Author:
- Caleb Rans
The highest-risk AEDs were zonisamide, rufinamide, clorazepate, lamotrigine, carbamazepine, and phenytoin.
News
First-line bortezomib prolongs survival in MCL
- Author:
- Caleb Rans
The survival benefits are promising with the addition of bortezomib, but there was no significant difference among high-risk patients.
News
Combo can prolong overall survival in MCL
- Author:
- Caleb Rans
Final results of a phase 3 trial suggest bortezomib plus rituximab and chemotherapy can significantly improve overall survival (OS) in transplant-...
News
Use of topical agents before RT may be safe
- Author:
- Caleb Rans
Using preclinical models, investigators found that when common topical agents were applied at a thickness of less than 2 mm, negligible effects on...
News
mRCC: Pazopanib appears safe in renal failure
- Author:
- Caleb Rans
Renal dysfunction at therapy initiation may not alter the efficacy and safety of pazopanib, with the exception of more frequent reductions in dose...